Sorafenib in hepatocellular carcinoma

被引：12
|
作者：
Josephs, Debra H. [1 ,2 ]
Ross, Paul J. [1 ,2 ]
机构：
[1] Guys & St Thomas Hosp, London SE1 9RT, England
[2] Kings Coll Hosp London, London, England
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2010年 / 71卷 / 08期
关键词：
RAF/MEK/ERK PATHWAY; TUMOR PROGRESSION; NATURAL-HISTORY; ANGIOGENESIS; ACTIVATION; EXPRESSION; MANAGEMENT; PROGNOSIS; APOPTOSIS; CIRRHOSIS;
D O I：
10.12968/hmed.2010.71.8.77669
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：451 / 456
页数：6
相关论文
共 50 条
  • [11] The Role of Sorafenib in Hepatocellular Carcinoma
    Gholam, Pierre
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (04) : 232 - 234
  • [12] Hepatocellular carcinoma management in the era of sorafenib
    Rosmorduc, O.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2009, 33 (04): : 327 - 333
  • [13] Sorafenib for hepatocellular carcinoma in real life
    Cidon, E. Una
    Alonso, P.
    ANNALS OF ONCOLOGY, 2021, 32 : S127 - S127
  • [14] Management of Hepatocellular Carcinoma: Beyond Sorafenib
    Chan, Stephen L.
    Mok, Tony
    Ma, Brigette B. Y.
    CURRENT ONCOLOGY REPORTS, 2012, 14 (03) : 257 - 266
  • [15] PERSONALIZED THERAPY WITH SORAFENIB FOR HEPATOCELLULAR CARCINOMA
    Cabibbo, G.
    Iavarone, M.
    Maida, M.
    Di Martino, A.
    Orlando, E.
    Zavaglia, C.
    Grieco, A.
    Villa, E.
    Piscaglia, F.
    Di Marco, V.
    Colombo, M.
    Craxi, A.
    Camma, C.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S397 - S397
  • [16] Sorafenib and radiotherapy association for hepatocellular carcinoma
    Girard, N.
    Mornex, F.
    CANCER RADIOTHERAPIE, 2011, 15 (01): : 77 - 80
  • [17] Selection of Patients with Hepatocellular Carcinoma for Sorafenib
    Abou-Alfa, Ghassan K.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 (04): : 397 - 403
  • [18] Mechanisms of sorafenib resistance in hepatocellular carcinoma
    Liang, Yuanjing
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (08)
  • [19] Effectiveness of sorafenib in the treatment of hepatocellular carcinoma
    Salamanca, P.
    Magalhaes, H.
    Carneiro, F.
    Marques, D.
    Faustino, C.
    Sousa, N.
    Machado, M.
    Ferreira, P.
    Raimundo, A.
    Fragoso, M.
    Lara Santos, L.
    Pereira, D.
    ANNALS OF ONCOLOGY, 2016, 27 : 52 - 52
  • [20] Sorafenib plus cisplatin for hepatocellular carcinoma
    Brower, Vicki
    LANCET ONCOLOGY, 2016, 17 (10): : E424 - E424
12345